Previous 10 | Next 10 |
Mario13/E+ via Getty Images FibroGen courts downgrades after FDA setback for Roxadustat FibroGen (FGEN) has lost ~35.7% in the pre-market in reaction to its failure to win the endorsement from FDA’s expert panel for Roxadustat in anemia due to chronic kidney diseas...
Live Webcast at 3:30 p.m. CT (4:30 p.m. ET) Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 fourth-quarter conference call on Wednesday, August 4, 2021, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss ...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host inve...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the full line of OrbusNeich ® JA...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a real-world optical coherence t...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a real-world optical coherence tomog...
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Cardiovascular Systems, Inc. 2021 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. Cardiovascular Systems Inc (NASDAQ: CSII) Q3 2021 Earnings Call May 6, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cardiovascular Systems Inc (CSII) Q3 2021 Earnings Call Transcrip...
Conference Call Scheduled for Today, May 6, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $63.3 million increased 3.4% compared to third quarter last year Net loss of $6.0 million includes $3.4 million related to acquisition of peripheral support catheters from Wa...
Lower cumulative procedure costs at one- and two-years when orbital atherectomy used Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with p...
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...